The FDA has said that an important supplement that is on the cutting edge of lifespan and health span research can no longer be sold as a supplement because it is being studied as a drug—another gift to drug monopolists! Action Alert!

The FDA pulled a similar reversal a few years ago with vinpocetine, now it is happening again with β-NMN (beta-nicotinamide mononucleotide, or simply NMN), an important supplement for anti-aging. We must protect access to this important supplement.

If this decision stands, consumers lose, and drug company monopolists win. NMN has a number of documented benefits: it has been found to suppress age-associated weight gain, enhance energy metabolism and physical activity, improve insulin sensitivity, improve eye function, and improve mitochondrial health. Some of these benefits may be associated with the fact that NMN is a precursor to NAD+, another crucial nutrient that is found in every cell in the body and is essential to life.